Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration

NCT03308994 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT03308994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03308994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Completed
Start date
November 1, 2017
Completion date
December 31, 2019
Enrollment
650 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

c10.114.375.500